Doximity's Stellar FY25 Will Be Tough Act to Follow -- Market Talk

Dow Jones

2025/05/16

1108 ET - Doximity's fiscal 2025, which ended March 31, was a strong growth year that fiscal 2026 will have a tough time topping, Mizuho analysts say in a research note. Sales rose 20% from strong revenue retention, particularly among Doximity's top 20 customers. The provider of a networking platform for healthcare professionals now has 116 customers contributing more than $500 million in annual subscription revenue, and those customers account for 84% of FY25's revenue, lowering the risk of small-customer churn, the analysts say. Doximity also grew revenue by 2 to 3 percentage points by shifting to more multi-module integrated offerings, they say. That tough comparison with FY25, along with rising macro uncertainty, explains why Doximity is only guiding for half as much revenue growth in FY26, the analysts say. (dean.seal@wsj.com)

(END) Dow Jones Newswires

May 16, 2025 11:08 ET (15:08 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2535698314"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2535698314\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2535698314?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-16 23:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535698314","market":"sh","top_or_hot":-1,"title":"Doximity's Stellar FY25 Will Be Tough Act to Follow -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1108 ET - Doximity's fiscal 2025, which ended March 31, was a strong growth year that fiscal 2026 will have a tough time topping, Mizuho analysts say in a research note. Sales rose 20% from strong revenue retention, particularly among Doximity's top 20 customers. The provider of a networking platform for healthcare professionals now has 116 customers contributing more than $500 million in annual subscription revenue, and those customers account for 84% of FY25's revenue, lowering the risk of small-customer churn, the analysts say. Doximity also grew revenue by 2 to 3 percentage points by shifting to more multi-module integrated offerings, they say. That tough comparison with FY25, along with rising macro uncertainty, explains why Doximity is only guiding for half as much revenue growth in FY26, the analysts say. (dean.seal@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 16, 2025 11:08 ET (15:08 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Doximity's Stellar FY25 Will Be Tough Act to Follow -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoximity's Stellar FY25 Will Be Tough Act to Follow -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-05-16 23:08</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1108 ET - Doximity's fiscal 2025, which ended March 31, was a strong growth year that fiscal 2026 will have a tough time topping, Mizuho analysts say in a research note. Sales rose 20% from strong revenue retention, particularly among Doximity's top 20 customers. The provider of a networking platform for healthcare professionals now has 116 customers contributing more than $500 million in annual subscription revenue, and those customers account for 84% of FY25's revenue, lowering the risk of small-customer churn, the analysts say. Doximity also grew revenue by 2 to 3 percentage points by shifting to more multi-module integrated offerings, they say. That tough comparison with FY25, along with rising macro uncertainty, explains why Doximity is only guiding for half as much revenue growth in FY26, the analysts say. (dean.seal@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 16, 2025 11:08 ET (15:08 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4551","symbol_name":"寇圖資本持倉","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2535698314","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535698314","pubTimestamp":1747408080,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1108 ET - Doximity's fiscal 2025, which ended March 31, was a strong growth year that fiscal 2026 will have a tough time topping, Mizuho analysts say in a research note. Sales rose 20% from strong revenue retention, particularly among Doximity's top 20 customers. The provider of a networking platform for healthcare professionals now has 116 customers contributing more than $500 million in annual subscription revenue, and those customers account for 84% of FY25's revenue, lowering the risk of small-customer churn, the analysts say. Doximity also grew revenue by 2 to 3 percentage points by shifting to more multi-module integrated offerings, they say. That tough comparison with FY25, along with rising macro uncertainty, explains why Doximity is only guiding for half as much revenue growth in FY26, the analysts say. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4551":"寇图资本持仓","BK4588":"碎股","BK4539":"次新股","BK4585":"ETF&股票定投概念","BK4613":"AI应用软件","DOCS":"Doximity, Inc.","BK4167":"医疗保健技术"},"translate_title":"Doximity在2025财年的出色表现将是一项艰难的行动——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DOCS":1},"content_text":"1108 ET - Doximity's fiscal 2025, which ended March 31, was a strong growth year that fiscal 2026 will have a tough time topping, Mizuho analysts say in a research note. Sales rose 20% from strong revenue retention, particularly among Doximity's top 20 customers. The provider of a networking platform for healthcare professionals now has 116 customers contributing more than $500 million in annual subscription revenue, and those customers account for 84% of FY25's revenue, lowering the risk of small-customer churn, the analysts say. Doximity also grew revenue by 2 to 3 percentage points by shifting to more multi-module integrated offerings, they say. That tough comparison with FY25, along with rising macro uncertainty, explains why Doximity is only guiding for half as much revenue growth in FY26, the analysts say. (dean.seal@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 16, 2025 11:08 ET (15:08 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}